Literature DB >> 8256226

Reoperative insulinomas, 1927 to 1992: an institutional experience.

G B Thompson1, F J Service, J A van Heerden, J A Carney, J W Charboneau, P C O'Brien, C S Grant.   

Abstract

BACKGROUND: Between 1927 and 1992, 313 patients have undergone surgery for insulinoma(s) at our institution, 12% of which were reoperations. We retrospectively reviewed all cases (n = 39) of reoperative surgery for persistent hyperinsulinism to identify changing patterns in surgical approach, morbidity, and outcome and to evaluate the influence of preoperative and intraoperative localization studies.
METHODS: The diagnosis of endogenous hyperinsulinism has evolved from satisfying Whipple's triad to documenting concomitant hypoglycemia and endogenous hyperinsulinemia. Thirty-nine patients were divided into two groups for comparison: those treated before localization studies were available (1927 to 1967) (n = 17) and those treated since that time (n = 22). Initial operations were also compared with reoperations among these 39 patients.
RESULTS: There were 26 women and 13 men (mean age, 42 years). There was at least one positive preoperative localization study in 16 of 22 patients (73%). Intraoperative ultrasonogram and careful palpation successfully identified 10 of 11 tumors in the reoperative setting. Blind or completion pancreatectomies were common before 1967 (10 of 17 patients). Since 1967, 14 of 22 patients have undergone enucleation of their primary tumor. Operative morbidity increased from 21% to 58% with reoperation but decreased from 65% to 29% (p = 0.026) when comparing the preangiography to the postangiography eras. The development of iatrogenic diabetes mellitus occurred in 13 patients (33%) after reoperation. Forty-one percent had diabetes before 1967 and 27% since that time (p = not significant). Thirty-four of 36 patients (94%) without malignant tumors were cured by reoperation. There was one operative death. Survival for patients who underwent completion or total pancreatectomy was significantly reduced (p = 0.003).
CONCLUSIONS: Reoperations for persistent hyperinsulinism can be highly successful in experienced hands. These reoperations, however, are associated with increased morbidity and iatrogenic diabetes. With experience and the use of selected localization studies, first-time failures can be avoided in most cases thus reducing the need for reoperations and its inherent sequelae.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256226

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  Impact of variant pancreatic arterial anatomy and overlap in regional perfusion on the interpretation of selective arterial calcium stimulation with hepatic venous sampling for preoperative localization of occult insulinoma.

Authors:  Scott M Thompson; Adrian Vella; F John Service; Clive S Grant; Geoffrey B Thompson; James C Andrews
Journal:  Surgery       Date:  2015-04-11       Impact factor: 3.982

Review 2.  Total pancreatectomy: indications, operative technique, and postoperative sequelae.

Authors:  David G Heidt; Charles Burant; Diane M Simeone
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

Review 3.  Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia.

Authors:  Ajay V Maker; Raashid Sheikh; Vinita Bhagia
Journal:  Langenbecks Arch Surg       Date:  2017-07-21       Impact factor: 3.445

4.  Malignant metastatic insulinoma-postoperative treatment and follow-up.

Authors:  Achim Starke; Christiane Saddig; Lothar Mansfeld; Rainer Koester; Cyrus Tschahargane; Peter Czygan; Peter Goretzki
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  Insulinoma--experience from 1950 to 1995.

Authors:  M P Boukhman; J H Karam; J Shaver; A E Siperstein; Q Y Duh; O H Clark
Journal:  West J Med       Date:  1998-08

6.  Combining the selective arterial calcium injection test and intraoperative blood glucose monitoring for multiple insulinomas: report of two cases.

Authors:  S Haji; H Nomura; K Yasuda; N Hashimoto; H Ohyanagi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

7.  Malignant insulinoma causing liver metastasis 8 years after the initial surgery: report of a case.

Authors:  N Sata; W Kimura; T Kanazawa; T Muto
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  [Total pancreatectomy: renaissance of a surgical procedure].

Authors:  T Keck; U T Hopt
Journal:  Chirurg       Date:  2008-12       Impact factor: 0.955

9.  Neuroendocrine tumors of the pancreas.

Authors:  Y Van Nieuwenhove; S Vandaele; B Op de Beeck; G Delvaux
Journal:  Surg Endosc       Date:  2003-08-15       Impact factor: 4.584

10.  Surgical management of insulinoma associated with multiple endocrine neoplasia type I.

Authors:  D S O'Riordain; T O'Brien; J A van Heerden; F J Service; C S Grant
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.